Viatris Inc (VTRS)
11.62
+0.16
(+1.44%)
USD |
NASDAQ |
Nov 05, 16:00
11.76
+0.14
(+1.20%)
After-Hours: 20:00
Viatris Debt to Equity Ratio: 0.876 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.876 |
| March 31, 2024 | 0.8975 |
| December 31, 2023 | 0.8854 |
| September 30, 2023 | 0.8807 |
| June 30, 2023 | 0.8925 |
| March 31, 2023 | 0.8971 |
| December 31, 2022 | 0.9143 |
| September 30, 2022 | 1.042 |
| June 30, 2022 | 1.06 |
| March 31, 2022 | 1.077 |
| December 31, 2021 | 1.126 |
| September 30, 2021 | 1.110 |
| June 30, 2021 | 1.151 |
| March 31, 2021 | 1.141 |
| December 31, 2020 | 1.126 |
| September 30, 2020 | 0.9834 |
| June 30, 2020 | 1.038 |
| March 31, 2020 | 1.126 |
| December 31, 2019 | 1.066 |
| September 30, 2019 | 1.140 |
| June 30, 2019 | 1.121 |
| March 31, 2019 | 1.160 |
| December 31, 2018 | 1.139 |
| September 30, 2018 | 1.199 |
| June 30, 2018 | 1.208 |
| Date | Value |
|---|---|
| March 31, 2018 | 1.148 |
| December 31, 2017 | 1.106 |
| September 30, 2017 | 1.112 |
| June 30, 2017 | 1.173 |
| March 31, 2017 | 1.289 |
| December 31, 2016 | 1.398 |
| September 30, 2016 | 1.337 |
| June 30, 2016 | 1.305 |
| March 31, 2016 | 0.7276 |
| December 31, 2015 | 0.7552 |
| September 30, 2015 | 0.6536 |
| June 30, 2015 | 0.8874 |
| March 31, 2015 | 0.9402 |
| December 31, 2014 | 2.612 |
| September 30, 2014 | 2.386 |
| June 30, 2014 | 2.467 |
| March 31, 2014 | 2.585 |
| December 31, 2013 | 2.730 |
| September 30, 2013 | 1.961 |
| June 30, 2013 | 2.124 |
| March 31, 2013 | 2.181 |
| December 31, 2012 | 1.716 |
| September 30, 2012 | 1.486 |
| June 30, 2012 | 1.780 |
| March 31, 2012 | 1.447 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.876
Minimum
Jun 2024
1.151
Maximum
Jun 2021
1.015
Average
1.042
Median
Sep 2022
Debt to Equity Ratio Benchmarks
| Lexicon Pharmaceuticals Inc | 0.4146 |
| Eli Lilly and Co | 2.185 |
| Amgen Inc | 8.024 |
| Gilead Sciences Inc | 1.277 |
| Perspective Therapeutics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 45.33B |
| Total Liabilities (Quarterly) | 25.81B |
| Shareholders Equity (Quarterly) | 19.52B |
| Current Ratio | 1.530 |
| Net Debt Paydown Yield | 2.64% |